Wells Fargo & Company INVIVO THERAPEUTICS HLDGS CO Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
N/A
-212 Closed
0 $0
Q1 2022

May 16, 2022
BUY
N/A
2 Added 0.95%
212 $0
Q4 2021

Feb 14, 2022
SELL
N/A
-2 Reduced 0.94%
210 $0
Q3 2021

Nov 15, 2021
SELL
N/A
-10 Reduced 4.5%
212 $0
Q2 2021

Aug 16, 2021
SELL
N/A
-2 Reduced 0.89%
222 $0
Q1 2021

May 13, 2021
BUY
N/A
84 Added 60.0%
224 $0
Q4 2020

Feb 09, 2021
BUY
N/A
108 Added 337.5%
140 $0
Q3 2020

Nov 05, 2020
BUY
N/A
20 Added 166.67%
32 $0
Q2 2020

Aug 13, 2020
BUY
N/A
6 Added 100.0%
12 $0
Q1 2020

May 14, 2020
BUY
N/A
6 New
6 $0
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email